Trial Profile
A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Assess the Safety, Tolerability, and Electrocardiographic Effects of Lofexidine When Administered Orally to Methadone Maintained Adult Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Feb 2022
Price :
$35
*
At a glance
- Drugs Lofexidine (Primary)
- Indications Opioid-related disorders
- Focus Adverse reactions
- Sponsors US WorldMeds
- 21 Nov 2014 New trial record